Tourette Syndrome and Chronic Tic Disorders

Area of Science:

• Genetics
• Neuroscience
• Clinical Medicine

Background:

• Tourette syndrome (TS) and chronic tic disorder (CTD) are neurodevelopmental conditions defined by persistent motor and vocal tics.
• Understanding the genetic underpinnings of TS/CTD is crucial for elucidating disease mechanisms and identifying potential therapeutic targets.

Purpose of the Study:

• To review modern genetic studies investigating the common and rare genetic variations associated with TS/CTD.
• To explore the relationship between genetic risk burden, tic severity, and familial aggregation in TS/CTD.

Main Methods:

• Analysis of common and rare genetic variations in individuals with TS/CTD.
• Quantification of genetic risk burden per patient.
• Identification of specific risk genes, including NRXN1 and CELSR3.

Main Results:

• Genetic risk burden in TS/CTD patients correlates with the severity of tics.
• Higher genetic risk is associated with a greater likelihood of a case being in a multiplex family (multiple affected individuals).
• Key genes like NRXN1 and CELSR3 have been identified as contributing to TS/CTD risk.

Conclusions:

• Modern genetic studies provide valuable insights into the etiology of TS/CTD by quantifying genetic risk.
• Genetic findings help define sources of patient risk and may inform future diagnostic approaches.
• While not immediately changing treatment, genetic insights advance the understanding of TS/CTD pathophysiology.